CN Patent

CN114010593A — 一种曲安奈德混悬注射液及制备方法

Assigned to Lemmer Beijing Pharmaceutical Technology Co ltd · Expires 2022-02-08 · 4y expired

What this patent protects

目的：讨论曲安奈德混悬注射液制备及药物配置时关键温度的选择，药物无菌保证水平的保证。通过稳定性研究保证药物的安全有效，结论：应用本专利下的制备工艺，可保证药品的安全有效。

USPTO Abstract

目的：讨论曲安奈德混悬注射液制备及药物配置时关键温度的选择，药物无菌保证水平的保证。通过稳定性研究保证药物的安全有效，结论：应用本专利下的制备工艺，可保证药品的安全有效。

Drugs covered by this patent

triamcinolone-acetonide (TRIAMCINOLONE ACETONIDE)

Patent Metadata

Patent number: CN114010593A
Jurisdiction: CN
Classification: —
Expires: 2022-02-08
Drug substance claim: No
Drug product claim: No
Assignee: Lemmer Beijing Pharmaceutical Technology Co ltd
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.